Abstract
INCREASED susceptibility to infectious disease is observed in iron-overloaded states such as β-thalassaemia major and in haemolytic states such as sickle cell disease or Bartonellosis1,2. The virulence of Escherichia coli, Listeria monocytogenes, Salmonella typhimurium and other pathogens can be increased by administration of iron compounds to the host, and transferrin-induced inhibition of bacterial growth can be reversed by saturating transferrin3–6. Plasma and secretory iron-binding proteins such as transferrin and lactoferrin may function in host defence by limiting the availability of iron to invading pathogens7. Many microorganisms synthesise iron-binding compounds when little iron is available8; these compounds may compete with host iron-binding mechanisms. We report here the effects of iron-chelating drugs on this competition for iron in S. typhimurium infection in normal and iron-overloaded mice. Desferrioxamine (DF), a hydroxamic acid, and2,3-dihydroxy-benzoic acid (2,3-DHB), a phenolic iron chelator, represent two classes of iron-chelating compounds which are being tested in chelation therapy for iron overload. Our data provide evidence that DF increases iron availability to wild type S. typhimurium, promoting bacterial growth and thus enhancing virulence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Caroline, L. & Kozinn, P. J. Ann. N.Y. Acad. Sci. 165, 148–155 (1969).
Barrett-Connor, E. Medicine, Baltimore 50, 97–112 (1971).
Bullen, J. J., Leigh, L. C. & Rogers, H. J. Immunology 85, 581–588 (1968).
Sword, C. P. J. Bact. 92, 536–542 (1966).
Purifoy, D. D., Wilkins, T. D. & Lankford, C. E. Bact. Proc. 55 (1966).
Caroline, L., Taschidjiam, C. L., Kozinn, P. J. & Schade, H. L. J. invest. Derm. 42, 415–419 (1964).
Weinberg, E. Science 184, 952–956 (1974).
Lankford, G. E. Crit. Rev. Microbiol. 2, 273 (1973); J. invest. Derm. 42, 415–419 (1964).
O'Brien, I. G., Cox, E. P. & Gibson, F. Biochim. biophys. Acta 177, 321–328 (1969).
Luckey, M., Pollack, J. R., Wayne, R., Ames, B. N. & Neilands, J. B. J. Bact. 111, 731–738 (1972).
Vogel, H. & Bonner, D. M. J. biol. Chem. 218, 97–106 (1956).
Cox, D. R. J. R. stat. Soc. 2, 187–220 (1972).
Walpole, R. E. Introduction to Statistics 196–200 (Macmillan, New York, 1969).
Weinberg, E. D. J. infect. Dis. 124, 401–410 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
JONES, R., PETERSON, C., GRADY, R. et al. Effects of iron chelators and iron overload on Salmonella infection. Nature 267, 63–65 (1977). https://doi.org/10.1038/267063a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/267063a0
This article is cited by
-
Iron traffics in circulation bound to a siderocalin (Ngal)–catechol complex
Nature Chemical Biology (2010)
-
Siderophores as antimicrobial agents
European Journal of Clinical Microbiology (1983)
-
Inhibition of bacterial multiplication by the iron chelator deferoxamine: Potentiating effect of ascorbic acid
European Journal of Clinical Microbiology (1983)
-
Iron and host defence
European Journal of Clinical Microbiology (1983)
-
Effect of iron deficiency on the cell mediated immune response
The Indian Journal of Pediatrics (1982)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.